# Concentration-controlled Therapy of Mycophenolate Mofetil (MMF) in Proliferative Lupus Nephritis

> **NCT01042457** · PHASE3 · COMPLETED · sponsor: **Chulalongkorn University** · enrollment: 24 (actual)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** Mycophenolate mofetil

## Key facts

- **NCT ID:** NCT01042457
- **Lead sponsor:** Chulalongkorn University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2013-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01042457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01042457, "Concentration-controlled Therapy of Mycophenolate Mofetil (MMF) in Proliferative Lupus Nephritis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01042457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*